Asthma Drug Xolair Increases Chances for Heart Attack
Asthma Drug Under Scrutiny The Food and Drug Administration issued a Safety Announcement warning that the asthma drug Xolair® increases the risk of heart attack, stroke, chest pain, and blood clots, among other serious problems. Xolair® is an injectable drug that was approved in 2003 to treat moderate to severe asthma in adults and children 12… Continue reading
